Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Myeloproliferative Disorders × Rivaroxaban × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 15 Venous Thromboembolism 13 Venous Thrombosis 5 Treatment of Venous Thromboembolism in Cancer Patients 3 Upper Extremity Deep Vein Thrombosis 2 Thrombosis 2 Pulmonary Embolism 2 Lung Neoplasms 2 Colonic Neoplasms 2 Urologic Neoplasms 1 Urogenital Neoplasms 1 Thromboembolism 1 Recurrence 1 Prostatic Neoplasms 1 Prevention of Venous Thromboembolism 1 Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Inflammation 1 Immune System Diseases 1 Hemorrhage 1 Glioma 1 Embolism 1 Dyskinesias 1 Cardiovascular Diseases 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 74 fludarabine phosphate 69 Peripheral Blood Stem Cell Transplantation 54 Mycophenolic Acid 46 Whole-Body Irradiation 45 Busulfan 45 Tacrolimus 44 Antilymphocyte Serum 39 fludarabine 37 Cyclosporine 36 Filgrastim 33 Cytarabine 29 Methotrexate 28 ruxolitinib 27 Melphalan 26 Radiotherapy 21 Etoposide 20 Azacitidine 19 Methylprednisolone 18 Sirolimus 14 Decitabine 14 Cord Blood Stem Cell Transplantation 14 Biopsy 14 Specimen Handling 13 Granulocyte Colony-Stimulating Factor 13 Flow Cytometry 13 thymoglobulin 12 venetoclax 11 Cyclosporins 11 Alemtuzumab 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04192916 2021-02-21

MPN-DOACs

FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS

Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡